Search hospitals > Ontario > TORONTO
Toronto Sunnybrook Regional Cancer Centre
Claim this profileTORONTO, Ontario M4N 3M5
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Prostate Cancer
Conducts research for Lymphoma
Conducts research for Brain Tumor
250 reported clinical trials
29 medical researchers
Summary
Toronto Sunnybrook Regional Cancer Centre is a medical facility located in TORONTO, Ontario. This center is recognized for care of Breast Cancer, Cancer, Prostate Cancer, Lymphoma, Brain Tumor and other specialties. Toronto Sunnybrook Regional Cancer Centre is involved with conducting 250 clinical trials across 191 conditions. There are 29 research doctors associated with this hospital, such as Paul Karanicolas, MD, PhD, Andrew Loblaw, MD, Gerard Morton, MD, FRCPC, and Helen MacKay, MD.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 positive
HER2 negative
2Cancer
Global LeaderStage IV
Stage III
Stage I
Top PIs
Paul Karanicolas, MD, PhDSunnybrook Health Sciences Centre6 years of reported clinical research
Studies Pancreatic Cancer
Studies Tumors
9 reported clinical trials
21 drugs studied
Andrew Loblaw, MDSunnybrook Health Sciences Centre6 years of reported clinical research
Studies Prostate Cancer
Studies Recurrence
7 reported clinical trials
9 drugs studied
Gerard Morton, MD, FRCPCOdette Cancer Centre6 years of reported clinical research
Studies Prostate Cancer
Studies Recurrence
6 reported clinical trials
8 drugs studied
Helen MacKay, MDSunnybrook Health Sciences Centre5 years of reported clinical research
Studies Ovarian Cancer
Studies Cancer
7 reported clinical trials
19 drugs studied
Clinical Trials running at Toronto Sunnybrook Regional Cancer Centre
Breast Cancer
Melanoma
Ovarian Tumors
Prostate Cancer
Ovarian Cancer
Colorectal Cancer
Pancreatic Cancer
Ovarian Carcinoma
Neuroendocrine Tumors
Fallopian Tube Cancer
Hypofractionated Radiotherapy
for Breast Cancer
This trial compares two radiation schedules for breast cancer patients to see if a shorter, higher-dose treatment is as effective as a longer, lower-dose one.
Recruiting2 awards Phase 33 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Toronto Sunnybrook Regional Cancer Centre?
Toronto Sunnybrook Regional Cancer Centre is a medical facility located in TORONTO, Ontario. This center is recognized for care of Breast Cancer, Cancer, Prostate Cancer, Lymphoma, Brain Tumor and other specialties. Toronto Sunnybrook Regional Cancer Centre is involved with conducting 250 clinical trials across 191 conditions. There are 29 research doctors associated with this hospital, such as Paul Karanicolas, MD, PhD, Andrew Loblaw, MD, Gerard Morton, MD, FRCPC, and Helen MacKay, MD.